Noninvasive Prenatal Diagnostics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Noninvasive Prenatal Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Noninvasive Prenatal Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Noninvasive Prenatal Diagnostics Overall Market Size
2.1 Global Noninvasive Prenatal Diagnostics Market Size: 2021 VS 2027
2.2 Global Noninvasive Prenatal Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Noninvasive Prenatal Diagnostics Players in Global Market
3.2 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue
3.3 Global Noninvasive Prenatal Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Prenatal Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Noninvasive Prenatal Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Noninvasive Prenatal Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Services
4.1.3 Instrument
4.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Noninvasive Prenatal Diagnostics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Personal
5.1.4 Other
5.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Noninvasive Prenatal Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Noninvasive Prenatal Diagnostics Revenue, 2016-2027
6.3.2 US Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Noninvasive Prenatal Diagnostics Revenue, 2016-2027
6.4.2 Germany Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.3 France Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.4 U.K. Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.5 Italy Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.6 Russia Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.4.8 Benelux Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Noninvasive Prenatal Diagnostics Revenue, 2016-2027
6.5.2 China Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.5.3 Japan Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.5.4 South Korea Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.5.6 India Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Noninvasive Prenatal Diagnostics Revenue, 2016-2027
6.6.2 Brazil Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.6.3 Argentina Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, 2016-2027
6.7.2 Turkey Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.7.3 Israel Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size, 2016-2027
6.7.5 UAE Noninvasive Prenatal Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 Natera
7.1.1 Natera Corporate Summary
7.1.2 Natera Business Overview
7.1.3 Natera Noninvasive Prenatal Diagnostics Major Product Offerings
7.1.4 Natera Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.1.5 Natera Key News
7.2 Illumina
7.2.1 Illumina Corporate Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Noninvasive Prenatal Diagnostics Major Product Offerings
7.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.2.5 Illumina Key News
7.3 BGI Diagnosis
7.3.1 BGI Diagnosis Corporate Summary
7.3.2 BGI Diagnosis Business Overview
7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Major Product Offerings
7.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.3.5 BGI Diagnosis Key News
7.4 Ariosa Diagnostics
7.4.1 Ariosa Diagnostics Corporate Summary
7.4.2 Ariosa Diagnostics Business Overview
7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.4.5 Ariosa Diagnostics Key News
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Corporate Summary
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.5.5 Quest Diagnostics Key News
7.6 Premaitha Health
7.6.1 Premaitha Health Corporate Summary
7.6.2 Premaitha Health Business Overview
7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Major Product Offerings
7.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.6.5 Premaitha Health Key News
7.7 NIPD Genetics
7.7.1 NIPD Genetics Corporate Summary
7.7.2 NIPD Genetics Business Overview
7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Major Product Offerings
7.4.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.7.5 NIPD Genetics Key News
7.8 Labcorp
7.8.1 Labcorp Corporate Summary
7.8.2 Labcorp Business Overview
7.8.3 Labcorp Noninvasive Prenatal Diagnostics Major Product Offerings
7.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.8.5 Labcorp Key News
7.9 Ravgen
7.9.1 Ravgen Corporate Summary
7.9.2 Ravgen Business Overview
7.9.3 Ravgen Noninvasive Prenatal Diagnostics Major Product Offerings
7.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.9.5 Ravgen Key News
7.10 LifeCodexx
7.10.1 LifeCodexx Corporate Summary
7.10.2 LifeCodexx Business Overview
7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Major Product Offerings
7.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.10.5 LifeCodexx Key News
7.11 TrovaGene
7.11.1 TrovaGene Corporate Summary
7.11.2 TrovaGene Business Overview
7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Major Product Offerings
7.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.11.5 TrovaGene Key News
7.12 Quest Diagnostics
7.12.1 Quest Diagnostics Corporate Summary
7.12.2 Quest Diagnostics Business Overview
7.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.12.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.12.5 Quest Diagnostics Key News
7.13 Berry Genomics
7.13.1 Berry Genomics Corporate Summary
7.13.2 Berry Genomics Business Overview
7.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Major Product Offerings
7.13.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue in Global (2016-2021)
7.13.5 Berry Genomics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Noninvasive Prenatal Diagnostics Market Opportunities & Trends in Global Market
Table 2. Noninvasive Prenatal Diagnostics Market Drivers in Global Market
Table 3. Noninvasive Prenatal Diagnostics Market Restraints in Global Market
Table 4. Key Players of Noninvasive Prenatal Diagnostics in Global Market
Table 5. Top Noninvasive Prenatal Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Noninvasive Prenatal Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Noninvasive Prenatal Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Noninvasive Prenatal Diagnostics Product Type
Table 9. List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Natera
Illumina
BGI Diagnosis
Ariosa Diagnostics
Quest Diagnostics
Premaitha Health
NIPD Genetics
Labcorp
Ravgen
LifeCodexx
TrovaGene
Quest Diagnostics
Berry Genomics